Foundation Medicine has appointed Cindy Perettie to serve as its CEO. Perettie comes to Cambridge, MA-based Foundation from Roche, where she was a senior vice president in global oncology product strategy for the company’s oncology unit. Perettie will start at Foundation on Feb. 4 succeeding Troy Cox, who has been CEO for the past two years.
Foundation analyzes blood samples of cancer patients for genetic information that helps guide treatment decisions. Pharmaceutical companies also use Foundation’s technology to identify patients for clinical trials. Last year, Roche paid $2.4 billion to acquire the part of Foundation that it did not already own.
